In this study, we report that mutations in the tyrosinase gene may serve as a novel possible factor contributing to enhanced NAFLD/NASH susceptibility and underlie a previously undescribed rapid hepatic inflammatory phenotype in B6 albino. This evidence concerns the gene TYR and metabolic dysfunction-associated steatohepatitis.